Funding Announcements
Apply for Grants
The Division of Cancer Treatment and Diagnosis funds a large portfolio of grants and contracts. The table below contains DCTD's current Notices of Funding Opportunities (NOFOs).
Please visit this page regularly for updates.
Funding Opportunities Supported by DCTD Programs
Title | Announcement Number | Expiration Date | Activity Code | Program/Contact |
---|---|---|---|---|
Imaging, biomarkers and digital pathomics for the early detection of premetastatic cancer and precancerous lesions associated with lethal phenotypes (Clinical Trial Optional) | PAR-22-131 | September 8, 2025 | R01 | CIP/Huiming Zhang |
Bioengineering Research Grants (Clinical Trial Optional) | PAR-22-243 | September 8, 2025 | R01 | CDP/Miguel Ossandon |
Bioengineering Research Grants (Clinical Trial Not Allowed) | PAR-22-242 | September 8, 2025 | R01 | CDP/Miguel Ossandon |
Coinfection and Cancer (Clinical Trial Not Allowed) | PAR-25-083 | January 8, 2026 | R21 | CIP/Pushpa Tandon |
Innovative Research in Cancer Nanotechnology (IRCN; Clinical Trial Not Allowed) | PAR-25-106 | May 5, 2026 | R01 | CIP NANO/Piotr Grodzinski and Leela Rani Avula |
Assay Development and Screening for Discovery of Chemical Probes, Drugs or Immunomodulators (Clinical Trial Not Allowed) | PAR-25-153 | September 8, 2026 | R01 | DTP/Suzanne Forry and Connie Sommers |
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 | PAR-23-284 | September 26, 2026 | P50 | TRP Staff |
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (Clinical Trial Not Allowed) | PAR-24-304 | October 15, 2026 | R01 | CDP/Sumana Dey |
Assay Validation of High Quality Markers for Clinical Studies in Cancer (Clinical Trial Not Allowed) | PAR-25-074 | October 15, 2026 | UH2/UH3 | CDP/Sumana Dey, CTEP/Minyung Song |
Assay Validation of High Quality Markers for Clinical Studies in Cancer (Clinical Trial Not Allowed) | PAR-25-075 | October 15, 2026 | UH2/UH3 | CDP/Sumana Dey, CTEP/Minyung Song |
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (Clinical Trials Optional) | PAR-25-079 | January 8, 2027 | R01 | CIP/Darrell Tata |
NCI's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (Clinical Trial Required) | PAR-25-081 | January 8, 2027 | R01 | CTEP/Lori A. Henderson, CIP/Lalitha Shankar, RRP/Jeff Buchsbaum, CDP/Magdalena Thurin, OCCAM/Dan Xi |
Notice of Special Interest (NOSI): Quantum Sensing Technologies in Biomedical Applications | NOT-EB-23-022 | January 27, 2027 | NOSI | RRP/Jeff Buchsbaum |
Research Projects to Develop Oncoaging Models for Cancer Research | NOT-CA-23-092 | July 31, 2027 | NOSI | DTP/Weiwei Chen |
Bioengineering Partnerships with Industry (Clinical Trial Optional) | PAR-24-325 | September 8, 2027 | U01 | CDP/Miguel Ossandon |
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (Clinical Trial Optional) | PAR-25-175 | January 8, 2028 | R01 | CIP Yisong Wang |
Molecular Imaging of Inflammation in Cancer (Clinical Trial Not Allowed) | PAR-24-311 | January 8, 2028 | R01 | CIP/Charles Lin |